NEW YORK (GenomeWeb News) – Thermo Fisher Scientific took charges of $18.2 million during the first quarter associated with a reduction in headcount of about 315 employees, the company said in its Form 10-Q this week.

The charges are cash costs related to headcount reductions and facility consolidations and consisted of severance to the employees who were laid off. It is unclear whether all 315 layoffs occurred in the first quarter ended March 31, however.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.